Cross-reactive CD4
Adult
Age Factors
Aged
Aged, 80 and over
Asymptomatic Diseases
BNT162 Vaccine
CD3 Complex
/ immunology
CD4-Positive T-Lymphocytes
/ immunology
COVID-19
/ immunology
COVID-19 Vaccines
/ immunology
Cross Reactions
Female
Humans
Immunity
Immunodominant Epitopes
/ immunology
Male
Middle Aged
Open Reading Frames
Peptide Fragments
/ immunology
SARS-CoV-2
/ genetics
Spike Glycoprotein, Coronavirus
/ immunology
Vaccination
Young Adult
Journal
Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511
Informations de publication
Date de publication:
08 Oct 2021
08 Oct 2021
Historique:
pubmed:
2
9
2021
medline:
15
10
2021
entrez:
1
9
2021
Statut:
ppublish
Résumé
The functional relevance of preexisting cross-immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a subject of intense debate. Here, we show that human endemic coronavirus (HCoV)–reactive and SARS-CoV-2–cross-reactive CD4
Identifiants
pubmed: 34465633
pii: science.abh1823
doi: 10.1126/science.abh1823
pmc: PMC10026850
doi:
Substances chimiques
CD3 Complex
0
COVID-19 Vaccines
0
Immunodominant Epitopes
0
Peptide Fragments
0
Spike Glycoprotein, Coronavirus
0
spike protein, SARS-CoV-2
0
BNT162 Vaccine
N38TVC63NU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
eabh1823Références
Nature. 2020 Aug;584(7821):457-462
pubmed: 32668444
Science. 2021 Apr 23;372(6540):363-370
pubmed: 33688062
Nat Rev Immunol. 2014 Jan;14(1):24-35
pubmed: 24336101
Sci Immunol. 2020 Jun 26;5(48):
pubmed: 32591408
J Exp Med. 2011 Jun 6;208(6):1243-52
pubmed: 21576382
Nature. 2021 Aug;596(7871):268-272
pubmed: 34107529
Sci Adv. 2021 Mar 5;7(10):
pubmed: 33674317
Lancet. 2021 Mar 6;397(10277):875-877
pubmed: 33610193
Sci Rep. 2020 Nov 4;10(1):18995
pubmed: 33149224
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
BMC Bioinformatics. 2010 Nov 22;11:568
pubmed: 21092157
Science. 2020 Dec 11;370(6522):1339-1343
pubmed: 33159009
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 32997649
PLoS Comput Biol. 2008 Apr 04;4(4):e1000048
pubmed: 18389056
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
Immunity. 2020 Nov 17;53(5):1095-1107.e3
pubmed: 33128877
Front Immunol. 2012 Apr 17;3:78
pubmed: 22566959
Cell. 2020 Oct 1;183(1):158-168.e14
pubmed: 32979941
Immunity. 2000 Nov;13(5):665-75
pubmed: 11114379
Nat Microbiol. 2020 Oct;5(10):1185-1191
pubmed: 32908214
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Commun Biol. 2021 Feb 12;4(1):225
pubmed: 33580175
Nat Immunol. 2021 Jan;22(1):74-85
pubmed: 32999467
Infection. 2020 Aug;48(4):619-626
pubmed: 32535877
Nature. 2020 Aug;584(7821):450-456
pubmed: 32698192
Clin Infect Dis. 2021 Sep 7;73(5):e1208-e1211
pubmed: 33270134
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
J Immunol. 2007 Nov 1;179(9):5877-85
pubmed: 17947661
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Science. 2020 Nov 27;370(6520):
pubmed: 32994364
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Immunity. 2020 Dec 15;53(6):1258-1271.e5
pubmed: 33296686
Nature. 2020 Nov;587(7833):270-274
pubmed: 32726801
Science. 2020 Oct 2;370(6512):89-94
pubmed: 32753554
Blood. 2009 Jan 22;113(4):769-74
pubmed: 18583570
J Mol Biol. 2017 Dec 8;429(24):3875-3892
pubmed: 29056462
Nat Rev Immunol. 2020 Nov;20(11):709-713
pubmed: 33024281
Eur J Immunol. 2021 Jul;51(7):1839-1849
pubmed: 33772767
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Blood. 2009 Feb 26;113(9):1948-56
pubmed: 19104082
Cell. 2021 Apr 1;184(7):1858-1864.e10
pubmed: 33631096
Nat Commun. 2020 Sep 17;11(1):4704
pubmed: 32943637
Cell Rep Med. 2021 Feb 16;2(2):100204
pubmed: 33521695
Elife. 2020 Feb 21;9:
pubmed: 32081129
Nat Commun. 2020 Jun 1;11(1):2806
pubmed: 32483236
J Clin Invest. 2021 Apr 1;131(7):
pubmed: 33571169
J Exp Med. 2009 Dec 21;206(13):2907-14
pubmed: 19934021
Front Immunol. 2021 May 28;12:635942
pubmed: 34127926